Access barriers for anti-cd19+chimeric antigen receptor t (car-t) cell therapy for non-hodgkin lymphoma (nhl) across a large community transplant and cellular therapy network

Transplantation and Cellular Therapy(2023)

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要